8/19/2019 Informe Final Consulta VIH
1/38
1
IFE DE A EI
C A C
IH
I IH I
Ca Paa, Paa, 79 2012
8/19/2019 Informe Final Consulta VIH
2/38
2
I ...................................................................................................................................... 3
C .................................................................................................................................................... 5
O a a ............................................................................................................................ 6
P a ............................................................................................................................. 6
S Vaa a VIH a a a a ............................................... 7
Ia aa a a aa a aa ............................................... 7
Vaa a aa VIH ............................................................................................. 7
Ma a ITS ....................................................................................................................... 8
V a a ............................................................................................. 8
Vaa a a .................................................. 9
Ia aa aa a a a . ............................................................... 9
Ra a a a ................................................................... 10
Aa .................................................................................................................................................... 15
Ra G aa............................................................................................................ 20
A 1. G aa aa a VIH ............................................................... 20
A 2. G aa aa a a VIH
a .............................................................................................................................................. 25
A 3. G aa aa a a ............................ 32
A 4. G aa aa a a ..................................................... 34
La aa .............................................................................................................................. 37
8/19/2019 Informe Final Consulta VIH
3/38
3
Da 3 a Aa Laa Ca Ea U Caa aa
aaa aa a a aa aa a
VIH. E a a a a a a a a VIH.
Paa 27 a a R a a aa a a. E aa a Ca Ra aa Aa Laa Ca
a a a a a aa a VIH a a a OPS,
a a a a aa Na Ua aa a a a
VIH/a (OPS/OMS, ONUSIDA, UNICEF, UNFPA), C aa C a P
Ea` Ea U (CDC), FGIZ Sa, a Oaa Ea Ca
Oa (OECO), COMISCA, ORAS aa aa.
Da , aa a a aa a
a VIH a a a (ITS), a a a
aa aa a a a a a a. E a a:
La aa VIH a aaa a VIH ( a a
a) a aa a a ( a).
La a a " a VIH
a aa a a ".
L a a a aa aa a a
a a a ( a, aa, aaa,
aa a).
• D a a a aa a aa a a
a a a a aa .
L a a aa aa aaaa,
a a ( a a, a
a a a) a aa a aa ( aa a,
a CD4 a aa aa).
La aa a aa a a
8/19/2019 Informe Final Consulta VIH
4/38
4
a aa a, aa a a a, aa aa a a a aa, a a a VIH.
La aa a aa a a aa a a a a
a a, a a aa a aa a a
aa, a a aa, aa a.
S a a a a a a a
, a a a.
La aa a a a
aa a a aa.
L aa a aa a a aaa aaa a a a
a a a a a a a a aa
a aaa a, a a a
aa a VIH, .
8/19/2019 Informe Final Consulta VIH
5/38
5
La Aa Laa Ca (ALC) a a a , a a , a a a a a VIH aaaa a a a a VIH.1 D aa, a a a a a a a
a a a aaa aa a a a VIH.Ta, aa ALC a aa aa 2 a a a a a a a VIH.24
Ta aa a, a a aa aa, aa a aaa aa, a aa aa a VIH.58 E aa a a a a a a a a a a a a aa a aa aaa aa a a a a.2023
E 2003, a Haaa, Ca, a a a a aa a VIH, aaa aa 2 a a a
a a R, a a a a a a a. Ea a R Ja 2005, aa a a a a a a VIH a a,a aa aa aa a ALC.
Aa a a a a a a aa a aa a a, a a a VIH aa a, a a a a aa a a VIH. La OMS a aa a a aa a aa a a aa a a aa, a aa a HIV, aaa aa a aa a a a, a a aa a
a a a VIH a aa, a aa a a a VIH2432. Ta a aa aa aa aa (aa, a a a a, aa a a a VIH) a a aa aa aa a a a a aa.
C a a a a aa a a a a aa a aa a aa ALC, aa a a a a a, aa a aa. P , aa a a.
E a , a aa a a (ITS) aa aa (a a aa a aa a aa a aa a ITS a (.. a), aa a a aa aa a a ITS. S a, a aa a a a aa ITS, a a a a aa aa aa a aaa a a ITS a .
8/19/2019 Informe Final Consulta VIH
6/38
6
L a :
a) Ra a a aa a a a a VIH ITS
) Ia a aa aa ALC a a a aa
a a a VIH a ITS.) La a a a aa a a a aa aa.
S aa a a a aa a a, aa, a a a.
Daa a aa aa aa a a aa a
a aa a a a a a a VIH/ITS I aa a a aa
a a a aa a VIH a aa a a
aa. C aa aa aa a aa
a a .
8/19/2019 Informe Final Consulta VIH
7/38
D
7
S a a aa VIH aaa a a a. Sa a a aa a a aa a a a aa a a a aa aa a VIH. E a a a a a a
aa a aa a a a VIH a a a a U Caa aa a aa a VIH a aa. Da a a a aa a aa a a a a a VIH.
E D. Ma G a a OPS a aa Taa2.0. E a a a aa a aaa aa aaa a aaa a a a VIH. La a VIH a a aa aa (TAR) aa, a a a a VIH a aa aa a a aa. E aa aa a a a aa a a a
aa a a. La a a a a a aaaa a , aa a a, a a VIH aa a ARN VIH aa. S a, a a a a a a VIH, a aa a a a a, a a a a aaaa a aa a a a aaa aa a a , a a a aa a a a VIH. E a a, a aa aa a aa a a VIH, a a a a a, aa, a aa a a aa a a
a aa. D a aa a a aa. La aa a aa aa a. E a a aa a aa aa a a a a aaa a.
IH
E 2012, a Oaa Ma a Sa a a a aa VIH a aa a a, aa a a a a aa a a a aa aa VIH.1
E a aaa a a a a a OMS aa a aa
a FRVIH a a aa a a aa.S a a a a a 4 aa: aa a aa a ; aa aa a a a a aaaa; aa aa a a aa a
E a a OMS a a:://..///a/2012//.
8/19/2019 Informe Final Consulta VIH
8/38
D
8
aa aa; a a aa 18 a.2
A a a Ia Aa Taa (IAT)3 a a OMS aa a a FRVIH. L IAT 2012 aa a a aa, aa aa, a aa aa, a aa a, aa a a aa a. S a aaa a aa aa a a a aa a a a a a a a aa aa.
E D. Ra S a a a a aa a ITS La Aa Ca a a a a OMS aa a ITS. Ea a a aaa a a a aa ITS a OMS4. E a a aa a ITS : a a (/ ), aa a aa ITS aaaa a a.
L aa aa a a aa a. Ia a a a aa aa ITS a. L aa a a aaa aa a ITS OMS, aa aa.
S a a aa a a a ITS, a a aaa aa a, a aaa. L a aa a a a aa aaa,a a a aaa.
T a a a a a, a ( a ITS) aa a a a aa( ) a. L aa a aa a aaa aaaa a. A, a aa aa aaaa/ a a a ,a a aa a aa aa a a, aa a aa. S a a aa, a a a. L a a a a OPS aaa a a aaa a aa a ITS.
La Da. Pa I, U, a aa a aa a Iaa Ea a a a a VIH a a a a a
M a a aa aa a FRVIH : ://..///a///. 3 La a a a a a IAT a a aa OMS:
://..////__//. 4 D :
://../a/a//9789241504478//.
8/19/2019 Informe Final Consulta VIH
9/38
D
9
a a a a a VIH a Ba a aa a a a aa, a D. G Fa.
C a a a aa a a VIH TB D. L Oa a a aa a aa aa a TBVIH. C a aa D. S a a E Saa a a a a aaaaa TB/VIH.
L a a a aa VIH aa a a a a . D aa aa aa a a a a a, a a , a a a a. E a a a a a a HSH. Ta aa a a a a a aa a. S a a aa a, a a aa a
a aa a aa VIH a a.
La a a a , a aaa a SIDA aa a a a a aa aa aaa a a VIH. E a aa a a a a aaa a aa a a , a a aa a, a a (MI). E MI, a aa aa a a a , a a a aa. S a a a aa MI Aa Laa Ca aa aa a Ia Eaa a
aa. S a a a: Q aaa a aa aa a ? C a aa a aa aa a a aa? La a Aa Laa Ca aa a a aa , P I B, a aa aa a a, a a a a a VIH a a a aa a a aa. E a Jaaa, a M Ga SIDA (MEGAS), M Ta (MT), E Sa aa a a Pa EaNaa, aa a a, a. C aa aaa a aa aa a a aa , a aa aa, aa a a
a. E Ma Ca Ra C Aa, B RaDaa a aa a aa a aa a aaa aa a a a ( aa a a ARV, a, , a aa aa a ) a a aaa a aa aa aa.
8/19/2019 Informe Final Consulta VIH
10/38
C
10
IH
a. L a aa aa a aa aa a a aa a VIH a a, a
a a VIH aa a aaa a a aa aa a VIH. La aa a VIH a aa aaa . Paa a a, a a aa aa a a a a.Ma a a aa a a a a a a a (aa, aa, aaa, aa a) a a VIH. E a a a a aa aa a a a a a aaa a.
. Aa, a a a a a VIH: . Ea VIH a a a a aa a.
. S a a a aa aa a CD4 a a aa a VIH.
. L a aa a a aaa a aaa a a. Da aa a a aa 1.
8/19/2019 Informe Final Consulta VIH
11/38
C
11
1.
C (, a, ..)*Fa aS La a Fa aUa aFa a **, a a aa ( a a), a a, a a, aaa. Ia ( aaa). EA a aa a aa a a a aaaa a aa a a.
** CD4Caa aFa ARV
** Fa * L a a a aaa a aa.**La a aa aa a a a a VIH.
. S a a a aa a a (a, ,a) ; ; a aa aaa ,
aaa, a a, a a, TB aa.
. La aa a a a a aaa a VIH. E aa a a a aa .
Paa aaa a aa aa a aa a VIH aa aa a a a aa, a a, aaa, aa, aa a (aa). L aa a a aa a , a a a a aaaa a a a a a aaa aa
a.
. E a aaa a a aa a a aa aa aaa a. P , a aa a aaa a a a a a a aaa aaa a.
8/19/2019 Informe Final Consulta VIH
12/38
C
12
. L aa a a a a a aa aaa a a. Ia, aaa a aaa a a a aa a a VIH (a a) a, aaaa a a a a a, aa a a aaa, a a aa aa.
. S a a a a aaa a.
. T a a a VIH , a a aa . P , a a a a a a aa aaa, a a a a VIH.
. S a a a a, a aa aa aaa a a (a a) aa a .Ma a a a , a aa aa.
I
E a a a a aa Paa VIH aa a a aa a aaa a a a,a a a a, aa, aa a aa, aaa a. E a a a a a a a a Iaa Taa 2.0 a Aa Laa Ca. Ea a a a aa aa a aa a aa a a . E
a a aaa a aaa a a a a a a a a aa ( aa a a ).
a. L aa a aa a a a aa a a a a a aa a aaa a a a,a, aa aa . A a a a aa a aaa a a aa aaaa a a aa aa.
. L aa a aa a a a a
aaa a a, aa a a aa a a a.
. A a a a a a aaa a a a a.
. Fa a a a aa a a aaa(a, a aa a) aa a a, HSH, TS, UDI.
8/19/2019 Informe Final Consulta VIH
13/38
C
13
. L aa aa a a aa aa a a aa a a a a AU, GARP, a aa, IAT, VIHTB,Iaa Ea.
I A a aa a a a ITS, a a aaa aa a, a aaa. S a, a aa a a a aa aaa,a a a aaa.
L aa a a aa a aa a ITS OMS, aa aa.
a. T a a a a a, a ( a ITS) aa a a aaa ( ) a. L aa a aa a a aa aaaa a. A, a aa
a a aaaa/ a aa , a a aa a aa aa aa, a a a aa.
. S a a aa, a a a. L a a a a OPS aaa a a aa a a aa a ITS.
I BIH La a aa a a a a aa a a aa VIH a T VIH.
a. S a a a a a, a a a aa a aa, a VIH a TB VIH. Aa aa a a a aa aa TBVIH.
L a a a aa a a aa a aaa, a a a aa, a a aa .
L a a a VIH a, a a, aaa a a a a
a (HSH, TS, UDI, .) a a aa a aa a.
a. La aa a a aa, aaaa aaa, aaaa a a a aaa .C a, a a a a a.
8/19/2019 Informe Final Consulta VIH
14/38
C
14
. Paa a a a a aa a aa VIH, a , , a aa, a a a, a a a. E a aa a a a a a a a a a a aa a a a a a a aa. L a a a ( 500,000 aa) a a a a a a a a aa a VIH.
L a a a a a aaaa a a a a, a aa, a a aa, aa aa aa aa a a. A aa aaa a aa a a a a a, aa a aaa aa aa a a a a a a aa, a a aa, aa a a a .
. S a a a a a, a a aa aa aa a a a , a aa a aa aa, a a a aa a aa a.A aa a aa a aa a aaa, aa, aa.
. S aa a a a a a aa a aa a aa , a a a a a aa.
. S a a aa a a aa a aa a
aa ONG a aa a aa a a a aa aa a a aa a a a a a .
8/19/2019 Informe Final Consulta VIH
15/38
A
15
1er Día .1er Día .1er Día .1er Día . Miércoles 7 de noviembre, 2012Miércoles 7 de noviembre, 2012Miércoles 7 de noviembre, 2012Miércoles 7 de noviembre, 2012Relator:Relator:Relator:Relator: Marcelo Vila, Nasim Farach, Clarisa BrezzoMarcelo Vila, Nasim Farach, Clarisa BrezzoMarcelo Vila, Nasim Farach, Clarisa BrezzoMarcelo Vila, Nasim Farach, Clarisa BrezzoFacilitadores: Eliseo Orellana (mañana) Claudia Vázquez (tarde)Facilitadores: Eliseo Orellana (mañana) Claudia Vázquez (tarde)Facilitadores: Eliseo Orellana (mañana) Claudia Vázquez (tarde)Facilitadores: Eliseo Orellana (mañana) Claudia Vázquez (tarde)
H F/D
7:308:00 I/Ra a
8:008:45 I, a
O
M Sa,PWRM. G
8:459:15 R aa aa aaa 2 a a a a a a
a a aa. 20
Pa/R a aa aa a a
aa a a a.R a a aa.
Ta Gaa Caa.OMS
9:1510:15 Ra aa aVaa a VIH(VCVIH)R .Q a a
aa a aa a?
I a :a) Vaa a
VIH a aa aIaa Ea aaa.
) Vaa CaaVa (CV) CD4:
aa.
Raaa 20
E: a Ha 15
E a
a aa aa a(aa CD4, CV):a Ba 15
Pa a10
I. Za (CDCGAPAaa)
M a Ha
M Sa Ba
10:1510:30 Oaa aa: aa
G aa.D aa ( ) aa. Paa 2aa aaa.
FaaEa aa 10
8/19/2019 Informe Final Consulta VIH
16/38
8/19/2019 Informe Final Consulta VIH
17/38
A
17
a OMS aa FRVIH(aa, TAR,aa a) aa a R.Pa 10
9:3012:30 Pa:Q a/a a aaaa aa TAR aa a R.
G.
.
Faa
12:3013:30 Ca13:3014:30 Ia a a
aa.D
Pa aa: 10
Faa
14:3015:00 Ma aITS: Q a a aa a aa a?
Eaa Ga a ITS Ra aOMS aa aa aITS. 20Pa .
Ra S (C ITS, OMS)
15:0016:00 Pa ITSa. Ia a aa a aa a
a aa a.
Fa
.
Faa
16:1517:15 I a a aa a
10 aa Faa
17:1518:15 E a a.
L a a : C a aa Pa a (PEMAR)
a a.1 a .Eaa a.
Faa
8/19/2019 Informe Final Consulta VIH
18/38
A
18
3er Día.3er Día.3er Día.3er Día. Viernes 9 de noviembre, 2012Viernes 9 de noviembre, 2012Viernes 9 de noviembre, 2012Viernes 9 de noviembre, 2012Relator (solo de mañana): Giovanni Ravasi, Karen Hymbaugh, Marjolein JacobsRelator (solo de mañana): Giovanni Ravasi, Karen Hymbaugh, Marjolein JacobsRelator (solo de mañana): Giovanni Ravasi, Karen Hymbaugh, Marjolein JacobsRelator (solo de mañana): Giovanni Ravasi, Karen Hymbaugh, Marjolein JacobsFacilitadores: Marc Connolly (mañana) Mónica AlonsoFacilitadores: Marc Connolly (mañana) Mónica AlonsoFacilitadores: Marc Connolly (mañana) Mónica AlonsoFacilitadores: Marc Connolly (mañana) Mónica Alonso González (tarde)González (tarde)González (tarde)González (tarde)
H F/D
8:15 Ba a 3. Pa 1
a aaa
Faa
8:3010:00 V a a:
• E a a a:Ta Ma aH.
• E a
a a:.
Ma VaaGa aa a Iaa Ea. UNICEF
Da VIH a a. Ba
TBVIH:Ma a (OPS)Ea E
Saa.
P: Pa I(UNICEF)Ma VaaGa aa a Iaa Ea VIH(Pa I, UNICEF)15
G Fa (MSPBa) 15
Raa L Oa (OPS)6D. Saa S (ESaa) 15
D aa a a 10
10:0010:15
10:1511:15 Ia aaaa a a a .
V a a Ra a aa a ( aMEGAS, ITV RNM) 15.E aa ALC.15D 20
ONUSIDA RSTLA
ONUSIDA RSTCa
11:1513:45 Vaa a aPa a :Q a
a a a?C aa a a?C a aa
Sa a aaaa aa. 15
Ma G aa a.
Ta Gaa Caa(OMS)
Faa
D aa
8/19/2019 Informe Final Consulta VIH
19/38
A
19
aa a?C aaa aa aa a a ?
13:4514:45 Ca
14:4516:30 Ra a a a .Pa a.
Paa aa.P a a aaa.
Faa
16:3017:00 C
8/19/2019 Informe Final Consulta VIH
20/38
A
20
La Ca a aa aa . La aa aa aa aa a aa a :
G 1: Gaaa, Ba, Ca Ra, Aa, Ea, OPS, USAID, ONUSIDA.G 2: Ca, Ua, P, Paa, Ca, M, OPS, CDC, UNFPA. G 3: Ha, E Saa, Ra Daa, Va, Paaa, Ba, CDC, COMISCA,ONUSIDA, Ha F, OPS, Oa A SaG 4: Ha, Ta & Ta, Jaaa, Baaa, Sa, Da, Gaa, B, CDC, PHa A Caaa.
:
G 1
T a a VIH. Ca VIH a a VIH a a aa a. D a a a, a aa. S a a a a aa aa.La Vaa aa a :N a ILa a: S aa a aS GLa aEa
Fa NaFa aVa : a a, a a , a a , aa TRANS, a aa a a, a aa a aaN aOaEa ( a ?)CD4Ea Ea C (a)
G 2
S a a a a a VIH aa a a a.La aa a a a VIH :Ia ,N,Fa a,S,Ea,Laa, M, a, a,Eaa,Ua a a,
8/19/2019 Informe Final Consulta VIH
21/38
A
21
Ma a(Sa: a,a, a;
Paa Sa: UDI,aa, aa),
E aaaa,
Fa a,Fa a aa.Ea a.
G 3
T aa a a a a a aa VIH. Laa aa a a VIH a a aa a.Vaa a:D: a, , aa, a a, / a, a(a a), a a, a a, a.C : a, , UDI, a a, aa.I : a, a, HSH.: CD4 Caa Va.F A.
F .
G 4
Y
• U F 2 a a a a
• S a aa- Naa- A- G- E
• Baa a- a a??
• CD4 a a a a CD4
• Va a a a a a a a• ART
• Da a
• Ca aB
• Ma
• N aa a a #
• AIDS/AIDS a a a a a
• A SOP
• A a a
• Ca
• Ia SOPSa a a UI (1
2 a a a a, DOB). N aa a. Ca
.I a UI a a a a? R I . T a a a a ID a a .Wa a aa ?Baaa: aa. T UI STI . E a a a .P a a . F Baaa a.A a HIV a . A a a
8/19/2019 Informe Final Consulta VIH
22/38
A
22
a a a DOB.Sa a a a HIV SaBaa: I a VCT . O a a a ( a aa) aa a .Jaaa a a aa aa VCT .Ta: Daa a a a a HIV a . R a
CAREC a .
:
G 1
E a a a, a a aa a VIH, aa a a aa a .Da a a a aa a a aa a a. S aa . Da a a a a aa a.
G 2
Ia a a aa, a a aa.Ia a.F a a.Caaa a.
G 3
Vaa a a a aa aa a a VIH.Fa a a aa aC a aa a.Fa a aa a a a aa.Ea aa a aa aa a a a VIH.Caaa a a aa a a a VIH.
G 4
• Ia a a /
• I a a aa aa: NGO aa aa a aa a
• M a a a CBS
• P a a
• La
• Aaa aa a MOH B
• UI a a
• I Ha a a a
• La a a
:
G 1
S a a a a a , a a a APS, aa, a , a a a a.
G 2
S a a a VIH .
8/19/2019 Informe Final Consulta VIH
23/38
A
23
E aa aa PTMI.B:
Faa a a aa.Faa aaa aa a a a .D a VIH aa,Taa , a a aa.
Va a aa (a a)Pa a RNS RN aa a a a a.
G 3
E a a a a VIH .B:
Pa .S a a .:
Sa a a aa.Raa a a.Aa a a .
G 4
Y a
• U
• D /
• M a a a a a a Baaa
• Daa a B
• C a a a a
• Ga aa
• L
• Paa
• Na a a
• A
: 4
4 ,
G 1
S a, a a a a a. E a, a a a a, a a a a a.Ha a a aa a aa CD4 CV.
G 2
E a a a CD4 CV; a a a a a a a a a a.
S a aa aa a a a a a.
G 3
D a a a a CD4 Caa a.Ba a a a a a a a.E a?
8/19/2019 Informe Final Consulta VIH
24/38
A
24
S.D a aa a a aa a a a a.D a a a aa a aa a a.
G 4
Y.
• Ia a aa • H a
• I aI a?YA :
• A
• Ia a a
• Ia a AIDS
• I a
• Ca a B
•
T, a a a• Ma
• Ca aa
• Ra a a
:
G 1
E a aaaa VIH
G 2
S a a a aa SIDA.
T a a SIDA,P aa a a aa ARV, a a aa a aa SIDA.
G 3
G 4
AIDS a a HIV . T a AIDS A :
• E a a a a
• Ia a
• G a a a a a/ aB
• Da
• CD4 a (aa) a a a AIDS
•
AIDS a a a HIV a (Da a). T a a• N a a a
8/19/2019 Informe Final Consulta VIH
25/38
A
25
:
E a a a a aa a 1. Da 35 a a a 22 a aa a aa a aa a aa. La a aa a a ( a a a a aa aa ) aa aa a aa a aa.
G 1: S aa a a a. E a aa a aa a.La aa aa a a a a, a a a a aa a ( , aa, a, aa) a aa a a a. Paa aa a , aa:a. La a a aa aa;. Aa a a;. Iaa a a VIH, aaa;. Q a aa a a aa a aaa a (aa a)G 2: Ea a a a a aa a, a aa a a aa a a. E USA, a aa, aaaaaaa, a a a aa a aa a a aa a a aa aa a a aa a, aa a a aa a a. E a, aa a a a aa a a a aa a a a.G 3: D a a a a a. S a aa a aa a a a aaa. D aa a a a.
G 4: D a a a aaa a aa a a aaa VIH ( CV). VIH.Caaa a a a aa aa .Aa a a a .
8/19/2019 Informe Final Consulta VIH
26/38
A
1. IH
Na: C : V = aa a; aa = a a, = aa a, Ca aaa
a. E a aaa a a a aaa .
8/19/2019 Informe Final Consulta VIH
27/38
A
27
A
: IH ( : 1 2)
, ..
IH (D:
) : HH, DI.
Ca
G 1
E a a, a a UDI aCaa a a a aa a aa.Pa a aa aa a a .
Aa
G 2La aa a a S a, a a a V aa a a a, a a aa a a aa.
Aa
IH .
G 1 E a a a a. Aa
G 2 T a a. Aa IH
.
G 1D a aa aaaa a aaaaaaa a a. (a aa a a a: aaa a a)
Aa
G 2D a a a a a a a a a aa aa.
Aa
B IH
.
G 1 Aa
G 2D a aa TB aa a a a,
a a aa a.
Aa
D CD4 ( CD4): /%
8/19/2019 Informe Final Consulta VIH
28/38
A
28
G 2N aa a a a a, aa a a a a a a a a.
Ia
HI .
G 1 S a aa Aa
G 2
La aa aa a a a a aa a a aa,
a a a, a a , aa aaa a aa. P a a aa aa. E a a a a aa a a. La aa aa a aa a aa.
Ia
: (G : 1 2) IH
IH (
CD4)
Ca G 1 S a Aa
G 2 Na: a aaa CD4, a: a aaa a. C a a a a a.
Aa
IH
I
G 1 Aa a a: a a aa a a aa
Aa
G 2 A a a, a a aa aa a a a a. P a a a a aa a, a a a aa a VIH a TB . S a a a a.
Ia
IH
B . G 1 Caa aa a TB a PVV. (Aa a a:
a a a a) Aa
G 2 Ia a a a, aa.
Baa
IH CD4 C
.
G 1 Iaa a a aa a aa aa a
Baa
G 2 Ya a aa Aa IH
(C) ( )
C ( : 2 )
G 1 (Aa a a: a a a aa a)
Ia
G 2 E a aa a aa.
Baa
.
G 1 S a aa Ia G 2 S aa a Vaa a, aa a aa a aa aa
aa ( a a aa) a a a aa,Aa/I
a
8/19/2019 Informe Final Consulta VIH
29/38
A
29
aa a ( a aa 3 ). O a aa aa a aaa a. E a, a a a a. T a aa a aa aa, a , a a a a.
: A (G : 3 4) :
,
.
Ca G 3 Aa a a a Aa G 4 W: a a
Daa MARPS MSM/SW/DU ART Ba: H ?% PHIV a: Y
Aa
A
(, )
G 3 S a aa Aa
G 4 G: . Y : Ba: N aa
N a a Pa 2 a 1
S: D, aa, 1 a 2 I aa a a a R
. Ea
Aa
.
G 3 Aaa a a a, a a aa Aa G 4 Ba: O aa (6590%) aa aa S:
C a , a a
Aa
A
A 12 .
G 3 D a DESABASTECIMIENTO aaaa Ra DaaC a a a a a
Aa
G 4 S a aa Aa # A
# %
% (4, ID, , )
G 3 S a aa AaG 4 N a: C aa a a
a a?
C a a a a a a?La a a a aa a a a
Aa
IH
B .
G 3 P a aa a Baa G 4 Baa
:
8/19/2019 Informe Final Consulta VIH
30/38
A
30
.
G 3 E a, a a; a . Aa G 4 Ba: La aa, a
D 1 & 2 I DR a a ??
Aa/Ia
B,
B IH. G 3 L a aa aa a.
S a a aa a TB/VIHE a a, a aa .Da a OMS.
Aa
G 4 Ia aLa aa a a a a aa aa VIH a a, a aaPa a a a VIHPa TB / VIH, a aa a aaLa aa a aa a aa TB a
Sa
B, B IH.
G 3 L a aa aa a. Sa a aa a TB/VIHE a a, a aa .Da a OMS.
Aa
G 4 Ca aM a a a a HIV a TB a a a aPa TB a HIVPa TB/HIV a a T a a a TB
Sa
A .
2 . G 3 P aa / aa
Taaa a a a Ia
G 4 Aa # VL a ART a. % ART 2 VL aD VL a a ARTa CD4
Aa
C A.
G 3 Paa ?, a: a a a Baa Ia aa a
G 4 D aa a a () ART a 1 ARTOaa a a
Sa
( D) G 3 D a aaaa Ra Daa
Ra a a a a Aa
G 4 Sa
: A (G : 3 4)
A
8/19/2019 Informe Final Consulta VIH
31/38
A
31
12 .
Ca
G 3 S a aa Aa G 4 S a aa Aa
A
24 .
G 3 S a aa Aa G 4 S a aa Aa
A
36 .
G 3 S a aa Aa G 4 S a aa Aa
A
60 .
G 3 S a aa Aa G 4 S a aa Aa
(: 2
12 , ≥2 CD4/
2 C / ) G 3 Da a a; CD4 a a a
; a a a. Ia
G 4 I VL aa a a ( a ART?) ......P a CD4 aa a
Aa
12
.
G 3 S a aa Aa G 4 A a . % a a ARV a a a
a a/a . S
a
: (G : 2, 3 4)
(C
8/19/2019 Informe Final Consulta VIH
32/38
A
32
G 1
E a:
• S a
• S a aa a a ( aa)
• S aa a a a: a , , a.
G 2
E a a a a aa ITS a a aa . N a a aa a a a a.La a a a a a aa a aa a.
G 3
• E a, a • Na a a aa, aa a; a a a
aa a a.• I a PEMAR aa a aa aa
G 4• Ua a• Ga • S (I Ca)• Ga• G, a, a• Fa ( CAREC)
Ra: Caa a a GC a a aa a ( . Baa, Baaa Caa a GC)
I
• S STI a ( a a ) aa Caa aa
CAREC• A STI a (S a Ga a a) a a• Ca S a - a - a a a - La a a a a a .
1. Aaa a a• Ca- N
2. S a a a a a a SW (SW a Caa)
• Ha a DR a a a SW a a
, 3
G 1
Laa a aa a S , a:
o S a a a a aaa aa (a a) a a (PEMAR)
o Pa a a a
8/19/2019 Informe Final Consulta VIH
33/38
A
33
o S a a a aa aa a aa a aa ITS
G 2
1. Caa a2. N a a a a a aa3. Aa aa a aa
G 3
• Pa a aa aa a a • Pa a a a a• Ba aaa a aa a , aa a
G 4
•
• (/)
:
•
•
, 3
G 1
E a:
• R a aaa a
• I
• A aaa / a a
• T aa a a a ITS
G 2
• Ea a a a aa a a a aa ITS a
• Ma a aaa a a
• Ia a .
G 3
N . G 4
• P a (Jaaa: MOU G a a aa)
• F /a a a (a a)• E a (a a )• La a a aa• I a STI
8/19/2019 Informe Final Consulta VIH
34/38
A
34
/
G 1
Sa a a: E a a a a a a a a.
G 2
E a aa aa aa aa: a a, a a a aa a, a aa aa.S a, a a a aa a a a, aa, a aa, a a a a a.P a a a PEMAR aa aa aa aa.
G 3
Q a a a a a a: N a, ,Caa a, a, a,Ca a?: a a a.C a a a a a a a?: aa a
a .G 4
• R a : Ca a a/R 23 Ha, Gaa, Sa,DR
• Daa a : 1. HIV/STIaa ,2. R a a a KAP a3. Sa a, a (a a a),4. S aa (NASA/MEGAS)
H a a ?Fa/RIa/aCa a a aa a a a? ( a ), a MARPS , a a a a a ( Aa, DR, Ta, Da), a G Aa M (Aa),S Aa (Jaaa)
G 1
E a aa a:• E a• Paa• C• Ra• A a a
Pa:• Faa• Paa• R aa aa • Raa aa• Ia aa a• A a a a
G 2
8/19/2019 Informe Final Consulta VIH
35/38
A
35
S Ia aaa a a , a, ( ), a aa VIH ITS. C, a, , a a a.Pa a : E a a a aa aa.La aa a a a a a a a a a, aa a.
E a a aaa a aa a a a a a a aa aa a a VIH. E a, F Ma a aaa aaaa a, a, . E M, a aaa a a a a a aa 100% a aaaa.
L a a a a a a a, a a a a aa a. C a a Taa 2.0, a a a a aa a a a a a, aa aa a a aa, aa a a a. Sa a a aa aa a aa aa a .
G 3
Q a a aaa a a a aa a?:aa a, a a a; ITS; a a; a a, a aa a.
• Q a a aa a?• Ta a aa • A (a a a aa).• Na a a a aaa aa a a a, a
aa a a a aaa.• F aa a a a a a aa a aa.• Ma aa a.• Pa a a a a a.
G 4
• M a
• Daa aa aa : aa aa a • Qa• S a• N a/a a (a:aa/)• E a a• L / S&D• A • Ca M&E a NGO aa a
• Va,• • Ra a ?• a a a• La a aa• Ba Sa • HR a aa (a )• C, a a aa HR,
(
...)
G 1
8/19/2019 Informe Final Consulta VIH
36/38
A
36
• Oa a a a a• Caa • Ia a• N a, a, a a, a• Raa a a
A
• Ma a aa a a• Pa aa a • Ma a aaa aa aaa • Taaa a a aa aa a a a.• Gaaa a
G 2
Ea a aa a a a a F Ma a 10 a, a Pa a aa aa a ; a a a aaa a a a a a a a a, a aa aa . Ta aa a a aa .La a a a aa a a a aa a aa .
G 3
• Paa a , aa a a E a.
• Vaa a a , aaa a.
• D a a a aa aa aa a PEMAR.
G 4
• a a aa/aa• Aa • S aa a a a
• Aaa • Ea a a • Ea a• R aa
• P aa • Aa a
8/19/2019 Informe Final Consulta VIH
37/38
37
Nombre Organismo E mail País
Aa, A M a a, Aa [email protected] Aa
Aa, Ga M a a, Paaa a.a.aa@a. Paaa
A G,
Ma
OPS, HQ a@a. Ea U
Aa, C PHAC, P Ha A Caaa [email protected] Caa
Aa A, Ja
Ca
M a, MINSA P aa@..
aaa_16@a.
P
Ba Ca, La M a, MINSA Paa aa@a. Paa
Ba, L CDC, Ra Daa a@. R. Daa
Baa, Paa ONUSIDA BaaP@a. P
B, Caa ONUSIDA B@a. Aa
Ca, Ja Ra M a a, Ha aa@a. Ha
Ca, Fa ONUSIDA a@a. Gaaa
Ca, La USAID Gaaa a@a. Gaaa
Ca, Ma M a a, Ua aa@.. Ua
C, Ma UNICEF @. PaaC A, R
Maa
Ha FGIZ @a. E Saa
Ca, Caa I Naa a, Ca a@a. Ca
D, Maa CDC 7@. Gaa
Ea, Pa OPSPHCO [email protected]. Ta & Ta
Faa, Na CDC aa@.. Ha
Ga Caa,
H E
Saa a, Ha a@a. Ha
Gaa Saa, E
J
M a a,
Gaaa
aa@a. Gaaa
GaaCaa, Ta OMS, HQ aa@. Sa
G, Ma OPS, HQ @a. Ea U
H, a CDC a4@. Ea U
Ha, Ka CDC 5@. Baa
I, Pa UNICEF @. USA
Ja, Ma ONUSIDA JaM@a. Paa
J, Maa M a, Baaa a.aaa@a. Baaa
K, L CONHUORAS @.. P
La A, Maa
Ia
M a a, Ca
MINSAP
a@.. Ca
La, Ha OPS, Paa a@a.. Paa
L Oa, Raa OPS, HQ a@a. USA
L, Ra M a, MINSA Paa a1812@a. Paa
La G, Na
I
Saa a, M [email protected].. M
Ma L, Ra M a a, E Saa a_a@a. E Saa
Maa, Maa M a a, Paa aaaa@a. Paa
Ma, D M a aa a
a, Va
a@a.
aaa@..
Va
Ma, V OPS, Paa a@a.. Paa
Ma, M COMISCA a@a. E Saa
8/19/2019 Informe Final Consulta VIH
38/38
M R, Ja J UNFPAUa @a. Ua
Ma, R OPS, Ea a@a. Ea
M WaB,
Raa
M a, Ta &
Ta
Raa.MW
B@a..
Ta & Ta
N, A M a, MINSA Paa a1@a. Paa
Oaa, E J A Ra Ha /GIZ aa@a. E Saa
Pa, G F. M a, Ba .a@a.. Ba
P, La M a, B @a.. B
Raaa, Ra M a, Ta &
Ta
Ra.Raaa@a.. Ta & Ta
Ra H,
Caaa
Caa Ca S Sa aaa529@a. Ca Ra
Raa, Ga OPS, Ba a.aa@a.. Ba
R, Pa M a, Da @a.. Da
Ra, Ea M a aa a
a, Va
@a. Va
Ra, Paa ONUSIDA CARIBE a@a. Ta & Ta
R, Maa
Aaa
M a a,
Ra Daa
a.aa@a. R. Daa
Sa, Ma A ONUSIDA SaMa@a. Ha
S, J Saa M a, MINSAL, E
Saa
@a..
@a.
E Saa
S, Ka ONUSIDA CARIBE @a. Ha
S, Ra C ITS, OMS 7@a. Iaa
S, Ja Ea ONUSIDA CARIBE SE@a. Jaaa
S, Da M a, Sa @a. Sa
Ta, R M a, Ea .a@.. Ea
Vaa, Caa M a, Ba a@a. Ba
V, Caa ONUSIDA VaC@a. Paa
Va, Ma OPS, Aa aa@a.. AaWa Gaa, J Caa Va Pa
C
a@a. R.
Daa/Jaaa
Za, I CDC 0@. Ea U
Top Related